A potent, selective, ATP-competitive mTORC1/2 dual inhibitor (IC50 = 2.81 nM against the isolated recombinant enzyme); exhibits >1,000-fold selectivity against all PI3K isoforms; has broad antiproliferative effects across multiple cell lines, reduces tumor growth in in vivo models of ER+ breast cancer, and acts as a radiosensitizer